Cdmo Services

KD LabService

Skip to main content

Explore about our broad range of CDMO Services and Products

news

KD Pharma Group completes acquisition of dsm-firmenich's marine lipids business

The transaction positions KD Pharma Group as the largest omega-3 manufacturer in the world 

More
news

KD Pharma Group announces acquisition of dsm-firmenich’s marine lipids business

The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two associated production sites in Canada and Peru
More
news

Groundbreaking collaboration between KD Pharma Group and DUDE CHEM

We are delighted to announce the collaboration between KD Pharma Group and DUDE CHEM, a fast growing deeptech company specialized in green chemistry manufacturing, for an impactful digitalization pilot project.
More
news

First place in the AOCS Laboratory Proficiency Program!

We are very proud to announce that our Quality Control team in KD Pharma Bexbach, Germany, has achieved the first place in the AOCS Laboratory Proficiency Program for GOED Nutraceutical Oils!
More
news

60% reduction of carbon emissions at our production sites in Germany

Environmental impact and sustainability have always played an important role in the KD Pharma Group's approach to business. Minimizing waste and improving overall efficiency are cornerstones of the organization.

More
news

Latest scientific findings about omega-3s

Have a look at the last scientific studies about Omega-3s in the links below:

More
news

New R&D laboratory and offices expansion

We are pleased to announce the opening of our new R&D laboratory and offices at our world-class synthesis and fractionation facility in Seal Sands, UK.

More
news

KD Pharma VP of sales, Uwe Westeppe, was interviewed at DCAT week

KD Pharma is a very dynamic, fast-growing company, that is constantly enlarging its technology toolbox for chemical transformations, purification and separation, and encapsulation under cGMP.

More
news

KD PHARMA FURTHER EXPANDS ITS CDMO CAPABILITIES IN THE UK MANUFATURING SITE

BIOGGIO, SWITZERLAND – October 18, 2021 – The KD Pharma Group has completed an expansion of its manufacturing site in Seal Sands, United Kingdom. The new modern plant followed a fast-track build project and triples the capacity of the site.

More
news

KD Pharma Group Acquires 51% Stake in Trigal Pharma

The KD Pharma Group has acquired a 51% stake in Trigal Pharma
More
Subscribe to